Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth <i>In Vivo</i>".

Comert Onder, Ferah; Kahraman, Nermin; Bellur Atici, Esen; Cagir, Ali; Kandemir, Hakan; Tatar, Gizem; Taskin Tok, Tugba; Kara, Goknur; Karliga, Bekir; Durdagi, Serdar; Ay, Mehmet; Ozpolat, Bulent

Correction to "Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo".

Comert Onder, Ferah; Kahraman, Nermin; Bellur Atici, Esen; Cagir, Ali; Kandemir, Hakan; Tatar, Gizem; Taskin Tok, Tugba; Kara, Goknur; Karliga, Bekir; Durdagi, Serdar; Ay, Mehmet; Ozpolat, Bulent.

ACS Pharmacol Transl Sci ; 4(3): 1247, 2021 Jun 11.

Article en En | MEDLINE | ID: mdl-34151214

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.1021/acsptsci.1c00030.].

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205232
https://dx.doi.org/10.1021/acsptsci.1c00113

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2021 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205232
https://dx.doi.org/10.1021/acsptsci.1c00113

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2021 Tipo del documento: Article